longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Innovative drug concept repeatedly active, ALK straight to the daily limit, Rundu Pharma previously sealed the board, InventisBio, Junshi Biosciences, HWPC, and Biokin Pharmaceutical rose more than 6%

Wallstreetcn
Apr 1, 2026 at 02:07 AM

Innovative drug concept repeatedly active, ALK straight to the daily limit, Rundu Pharma previously sealed the board, InventisBio, Junshi Biosciences, HWPC, and Biokin Pharmaceutical rose more than 6%.

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings

  • Apr 22, 2026 at 10:30 AMInnovative Drug Revenue Share Surpasses 60% for First Time, HENGRUI PHARMA Q1 Revenue Hits 8.14 Billion Yuan, Net Profit…
  • Apr 2, 2026 at 07:24 PMOfficial Announcement: US Maintains 50% Metal Tariffs, Imposes 25% Tariffs on Some Finished Products, 100% on Patented D…
  • Mar 27, 2026 at 05:24 AMBuying Platforms, Selling Pipelines: Deconstructing the Innovation Logic of SINO BIOPHARM
  • Mar 26, 2026 at 07:03 AMThe Reality and Illusion of "AI Drug Discovery" XTALPI's Turnaround
  • Mar 25, 2026 at 07:02 AMStronger After No Longer "Flying Solo"

Related Stocks

Rundu Pharma

Rundu Pharma

SZ002923

InventisBio

InventisBio

SH688382

BIOKIN PHARMACEUTICAL

BIOKIN PHARMACEUTICAL

SH688506

LongbridgeAI